2019
DOI: 10.1016/j.intimp.2018.11.050
|View full text |Cite
|
Sign up to set email alerts
|

Midazolam suppresses the lipopolysaccharide-stimulated immune responses of human macrophages via translocator protein signaling

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
21
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 27 publications
(22 citation statements)
references
References 46 publications
1
21
0
Order By: Relevance
“…In the human macrophage cell line THP-1, exposure to Midazolam, a TSPO binding agent, suppressed LPS-induced inflammatory responses, including IL-6 expression, NO and NF-κB and MAPK activation. This was specific for TSPO, as TSPO knockout cells did not show this effect [100]. Hence, TSPO interacts with inflammation pathways at the transcriptional level, manifesting in the immunomodulatory effects described in this review.…”
Section: Molecular Pathways Of Tspo Immunomodulationmentioning
confidence: 71%
“…In the human macrophage cell line THP-1, exposure to Midazolam, a TSPO binding agent, suppressed LPS-induced inflammatory responses, including IL-6 expression, NO and NF-κB and MAPK activation. This was specific for TSPO, as TSPO knockout cells did not show this effect [100]. Hence, TSPO interacts with inflammation pathways at the transcriptional level, manifesting in the immunomodulatory effects described in this review.…”
Section: Molecular Pathways Of Tspo Immunomodulationmentioning
confidence: 71%
“…The benzodiazepine midazolam targeted TSPO, a peripheral benzodiazepine receptor [ 14 ], also activated by LPS in the model. Midazolam is known to suppress the LPS-stimulated immune responses of human macrophages via TSPO signaling [ 15 ], but the model did not identify possible neuroprotective pathways for this agent.…”
Section: Discussionmentioning
confidence: 99%
“…Our animals were premedicated with midazolam and ketamine and were anesthetized with propofol and fentanyl. Midazolam may modulate the immune system by binding to the peripheral receptor of macrophages and inhibiting the proinflammatory responses [ 21 ], while ketamine acts at different levels of inflammation, interacting with inflammatory cell recruitment, cytokine production (IL-6, TNF- α ), and regulation of inflammatory mediators [ 12 ], which could explain in-part the nonsignificant increase in white blood cells. Also, propofol exerts inhibitory effects on neutrophil and monocyte function under different physiological and pathological circumstances, while the effects of cisatracurium and fentanyl are diverse in different disease states and must be further studied [ 22 , 23 ].…”
Section: Discussionmentioning
confidence: 99%